Prelude Therapeutics Inc
PRLDDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
5wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How PRLD's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PRT3789 | Phase 2 | Advanced Solid Tumor | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Prelude Therapeutics Inc's drug pipeline?→
CatalystAlert tracks 1 drug candidate in Prelude Therapeutics Inc's (PRLD) pipeline across Phase 2. Its lead program is PRT3789 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Prelude Therapeutics Inc's next FDA catalyst?→
Prelude Therapeutics Inc's (PRLD) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PRLD biotech catalysts?→
Add PRLD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Prelude Therapeutics Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.